Nevertheless, we showed no associations between IL28B polymorphisms and pretreatment clinical characteristics, and therefore excluded the influence of steatosis and other clinical factors in the relationship between IL28B and the expression of the tested genes. This evidence concerns the gene IFNL3 and steatosis.